Navi Mumbai, Maharashtra, India, December 2024 – Sailendra Goswami has joined Sitec Labs Pvt Ltd, a subsidiary of Cipla Ltd, as Director. In this leadership role, Sailendra will oversee clinical research, bioequivalence studies, and analytical research and development for regulatory filings, bringing his vast expertise in the contract research and pharmaceutical industry to advance Sitec Labs’ mission.
Sailendra brings over two decades of leadership experience in clinical research organizations (CROs) and pharmaceutical companies. Most recently, he served as President at Veeda Clinical Research Limited, where he spearheaded advancements in clinical trial services and bioequivalence studies.
Previously, Sailendra held top leadership roles at ENEM NOSTRUM REMEDIES PRIVATE LIMITED and Admerus Biosciences Pvt. Ltd., including President and Chief Executive Officer, driving growth strategies for CRO services, clinical trials, and regulatory compliance.
At Raptim Research Ltd., he excelled as President, managing and enhancing clinical trial operations for nearly six years. His earlier roles include leadership at Synergicus Research Solutions Pvt. Ltd., Cadila Pharmaceuticals Ltd., and GVK Biosciences Pvt. Ltd., where he contributed to strategic initiatives in mergers, acquisitions, and clinical development.
Sailendra’s career began with scientific and managerial roles at organizations like Lambda Therapeutic Research and Veeda Clinical Research Pvt. Ltd., where he established a foundation in clinical operations and research management.
About Sitec Labs Pvt Ltd
Founded in December 2004, Sitec Labs Pvt Ltd is an ISO 9001:2015 Contract Research Organization (CRO) committed to delivering the highest quality standards in the fields of bioequivalence and analytical research. The company excels in providing end-to-end solutions in clinical and analytical areas for pharmaceuticals and offers consultancy services in these domains.
Sitec Labs specializes in the synthesis of impurities, metabolites, and stable isotopes for drug products and APIs, utilizing state-of-the-art technologies such as LC-MS/MS, HPLC, and preparative HPLC. The company’s services include isolation, identification, characterization, and synthesis of pharmaceutical-related substances. With a strong foundation in quality and innovation, Sitec Labs supports regulatory compliance and drives advancements in the pharmaceutical industry.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
